Caliber Imaging & Diagnostics (LCDX) Stock Price
Caliber Imaging & Diagnostics Price
Over the last 4 years Caliber Imaging & Diagnostics grew revenue by 9.8% annually, reaching 3.34 M USD. For Caliber Imaging & Diagnostics, the net margin of -164.0% is up versus -176.0% a few years ago.
Caliber Imaging & Diagnostics stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Caliber Imaging & Diagnostics business model & stock analysis
Frequently asked questions about Caliber Imaging & Diagnostics
The business model of Caliber Imaging & Diagnostics Inc revolves around delivering innovative and advanced medical imaging solutions. As a leading provider in the healthcare industry, Caliber Imaging & Diagnostics specializes in developing cutting-edge systems for the diagnosis, treatment, and monitoring of various medical conditions. Their state-of-the-art products and technologies enable high-resolution cellular imaging, offering physicians and researchers comprehensive insights for improved patient care. With a strong commitment to advancing medical imaging capabilities, Caliber Imaging & Diagnostics Inc continues to revolutionize the field of diagnostics, empowering healthcare professionals to make accurate and timely medical decisions.
Caliber Imaging & Diagnostics Inc is primarily active in the healthcare and medical device industries.
The main competitors of Caliber Imaging & Diagnostics Inc in the market are typically companies such as Veracyte, Leica Biosystems, and MetaSystems.
Caliber Imaging & Diagnostics Inc, commonly known as Caliber I.D., is a leading company specializing in cutting-edge imaging and diagnostics solutions. Established in 2007, the company has rapidly grown to become a trusted provider of innovative medical devices and software. Caliber I.D. offers non-invasive, high-resolution imaging tools that aid in the early detection and diagnosis of various diseases, including skin cancer. With a commitment to improving patient care and outcomes, Caliber I.D. continues to develop advanced technologies that assist medical professionals in making accurate diagnoses. The company's dedication to research, development, and innovation has solidified its position as a respected player in the medical imaging industry.
Caliber Imaging & Diagnostics Inc (Caliber ID) has achieved several significant milestones. The company introduced the VivaScope®, a non-invasive imaging technology, which revolutionized the field of cellular imaging and diagnostics. Caliber ID received FDA clearance for the VivaScope® system, enabling its use in diagnosing and monitoring various skin conditions, including non-melanoma skin cancer. The company also launched the VivaScan™, a handheld version of the VivaScope® device, expanding its reach and potential applications. Caliber ID's accomplishments include partnerships with leading healthcare organizations and key opinion leaders, further validating the effectiveness of their technology. Overall, Caliber Imaging & Diagnostics Inc has made remarkable strides in the development and commercialization of innovative diagnostic imaging solutions.
Caliber Imaging & Diagnostics Inc is primarily present in the United States.
Caliber Imaging & Diagnostics Inc represents values of innovation, reliability, and cutting-edge technology. As a company in the medical technology industry, Caliber Imaging & Diagnostics Inc is dedicated to providing advanced imaging and diagnostic solutions for improved patient care. With a focus on precision, accuracy, and efficiency, the company delivers quality products that aid in early detection and diagnosis of diseases. Caliber Imaging & Diagnostics Inc follows a corporate philosophy that prioritizes research, development, and a commitment to delivering the best-in-class medical imaging systems. By combining expertise, sophisticated technologies, and a customer-centric approach, Caliber Imaging & Diagnostics Inc continues to revolutionize the medical imaging landscape.
Converted at the current exchange rate, the Caliber Imaging & Diagnostics share trades at 0.00 EUR (0.00 USD).
Caliber Imaging & Diagnostics Inc. is a rising company in the field of biotechnology, focusing on the development of advanced systems for the diagnosis of common diseases. The company offers innovative product solutions for various industries, including medicine and veterinary. The products are tailored to the customers' needs and are known for their high reliability and accuracy. The business model of Caliber Imaging & Diagnostics includes several divisions specialized in different product categories. The key products currently are the VivaScope, ISO, and SBV-HR. The company works closely with its customers to ensure their requirements are met. Caliber Imaging & Diagnostics aims to take a leading position in the field of medical biotechnology through innovative products, excellent customer service, and collaboration with professionals. The company remains committed to developing and refining its products and services to fully satisfy the needs and demands of its customers. With the VivaScope, ISO, and SBV-HR systems, Caliber Imaging & Diagnostics has developed an excellent portfolio of products that provide reliable information and diagnoses. The company aims to strengthen its market position and continue developing innovative solutions to ultimately contribute to better healthcare.
The revenue cannot currently be calculated for Caliber Imaging & Diagnostics.
The profit cannot currently be calculated for Caliber Imaging & Diagnostics.
The P/E ratio cannot be calculated for Caliber Imaging & Diagnostics at the moment.
The P/S cannot be calculated for Caliber Imaging & Diagnostics currently.
The Eulerpool Quality Score for Caliber Imaging & Diagnostics is 3/10.
The ISIN of Caliber Imaging & Diagnostics is US13001C1053. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Caliber Imaging & Diagnostics is A2QCBX. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Caliber Imaging & Diagnostics is LCDX. The ticker symbol is used to trade Caliber Imaging & Diagnostics shares on the stock exchange.
Caliber Imaging & Diagnostics stock
Caliber Imaging & Diagnostics Peer Group
Caliber Imaging & Diagnostics Ticker
Caliber Imaging & Diagnostics FIGI
All fundamentals and in-depth analysis of Caliber Imaging & Diagnostics
Our stock analysis for Caliber Imaging & Diagnostics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Caliber Imaging & Diagnostics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.